Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 02, 2016	Jul. 04, 2015
Cash flows from operating activities:
Net income	$ 36,654	$ 6,761
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	141,787	132,643
Loss on disposal of property, plant, equipment and other assets	827	233
Gain on insurance proceeds from insurance settlements	(356)	(341)
Deferred taxes	(1,812)	(3,225)
Increase/(decrease) in long-term pension liability	(1,596)	350
Stock-based compensation expense	5,067	4,642
Write-off deferred loan costs	57	10,633
Deferred loan cost amortization	5,600	4,868
Equity in net income of unconsolidated subsidiaries	(19,495)	(2,364)
Proceeds from Equity Method Investment, Dividends or Distributions	25,994	26,155
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(20,081)	22,582
Income taxes refundable/payable	1,559	(1,368)
Inventories and prepaid expenses	(19,501)	(21,451)
Accounts payable and accrued expenses	30,989	(1,505)
Other	(17,460)	8,937
Net cash provided by operating activities	168,233	187,550
Cash flows from investing activities:
Capital expenditures	(109,406)	(98,722)
Acquisitions, net of cash acquired	(8,511)	0
Gross proceeds from disposal of property, plant and equipment and other assets	2,404	1,484
Proceeds from insurance settlement	1,537	341
Payments related to routes and other intangibles	0	(2,242)
Net cash used by investing activities	(113,976)	(99,139)
Cash flows from financing activities:
Proceeds from long-term debt	17,277	579,974
Payments on long-term debt	(59,255)	(583,736)
Borrowings from revolving credit facility	41,000	41,244
Payments on revolving credit facility	(47,207)	(83,506)
Net cash overdraft financing	0	(880)
Deferred loan costs	0	(11,629)
Issuance of common stock	143	171
Repurchase of treasury stock	(5,000)	0
Minimum withholding taxes paid on stock awards	(1,812)	(4,775)
Excess tax benefits from stock-based compensation	(413)	(12)
Distributions to noncontrolling interests	0	(1,866)
Net cash used by financing activities	(55,267)	(65,015)
Effect of exchange rate changes on cash	1,941	(6,160)
Net increase in cash and cash equivalents	931	17,236
Cash and cash equivalents at beginning of period	156,884	108,784
Cash and cash equivalents at end of period	157,815	126,020
Supplemental disclosure of cash flow information:
Accrued capital expenditures	(3,684)	274
Cash paid during the period for:
Interest, net of capitalized interest	41,813	37,524
Income taxes, net of refunds	11,799	11,436
Debt issued for assets	10	2,521
Contribution of assets to unconsolidated subsidiary	$ 2,674	$ 0